Quantitative assessment of cortical synaptic density in Alzheimer's disease.
about
Mild cognitive impairment: pathology and mechanisms.Synthesis and in vitro and in vivo evaluation of 18F-labeled positron emission tomography (PET) ligands for imaging the vesicular acetylcholine transporterSoluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's diseaseNeurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's diseaseCalcium/calmodulin-dependent kinase II and Alzheimer's diseaseGene expression parallels synaptic excitability and plasticity changes in Alzheimer's diseasePathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body diseaseAmyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer diseaseNeuropathological alterations in Alzheimer diseaseChronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's DiseaseThe Eye As a Biomarker for Alzheimer's DiseaseNeuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?Transient elevation of synaptosomal mitoenergetic proteins and Hsp70 early in a rat model of chronic cerebrovascular hypoperfusionAlzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons.Tau-mediated synaptic damage in Alzheimer's diseaseMemory impairment in transgenic Alzheimer mice requires cellular prion protein.Nitrone-based therapeutics for neurodegenerative diseases: their use alone or in combination with lanthionines.Reduced IGF-1 signaling delays age-associated proteotoxicity in miceApoE4 induces Aβ42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice.AAV2 mediated retrograde transduction of corticospinal motor neurons reveals initial and selective apical dendrite degeneration in ALS.Synthesis and in vitro biological evaluation of carbonyl group-containing inhibitors of vesicular acetylcholine transporterTransgenic autoinhibition of p21-activated kinase exacerbates synaptic impairments and fronto-dependent behavioral deficits in an animal model of Alzheimer's disease.Functional brain imaging in the resting state and during activation in Alzheimer's disease. Implications for disease mechanisms involving oxidative phosphorylation.The Intersection of NGF/TrkA Signaling and Amyloid Precursor Protein Processing in Alzheimer's Disease NeuropathologyRanBP9 overexpression accelerates loss of dendritic spines in a mouse model of Alzheimer's diseaseCerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure.Intersection between metabolic dysfunction, high fat diet consumption, and brain aging.Protein tau: prime cause of synaptic and neuronal degeneration in Alzheimer's disease.Antioxidants have a rapid and long-lasting effect on neuritic abnormalities in APP:PS1 mice.Fractionating verbal episodic memory in Alzheimer's diseaseIs synaptic loss a unique hallmark of Alzheimer's disease?Immunotherapy alleviates amyloid-associated synaptic pathology in an Alzheimer's disease mouse model.Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons.Early fear memory defects are associated with altered synaptic plasticity and molecular architecture in the TgCRND8 Alzheimer's disease mouse model.Synapse loss in dementias.Intrinsic bioenergetic properties and stress sensitivity of dopaminergic synaptosomes.Neuroplasticity in Alzheimer's disease.Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease.Tau causes synapse loss without disrupting calcium homeostasis in the rTg4510 model of tauopathyLooking backward to move forward: early detection of neurodegenerative disorders.
P2860
Q24631255-9CBDFACD-8436-4CC6-B989-265B80A56189Q24650088-25688341-DD76-486C-9183-DE14E5BA9831Q24670696-DA4FF458-5CB1-47C8-9FE3-96A20422B03CQ26741247-1A502B79-A053-433C-82A6-3D430E567BE9Q26776012-6CB04043-FC48-401F-A078-355164963497Q26785375-71CDBE3D-63CE-4328-A1A8-13927ED7625FQ26853610-8A5DBFDA-7716-4BF4-89A0-C9B01BD8ED32Q26866265-B03E8F5B-635D-40E3-A899-37E817B2157FQ27003314-19E21CB3-641E-47E9-A281-4F851CC64783Q27346441-6036F110-D627-495F-ABF1-EB2670CC17C9Q28070142-A32C9FE8-EA85-4CF7-B6AA-2C68D4AA2D63Q28070156-18F1E408-8CC9-4F14-9C1E-A6517837FEDFQ28571124-1EEA3B19-5752-41D5-A056-2B0915FD98D5Q28771398-72EEEB55-F28B-4152-AC5E-B18C89E5392AQ28831067-871DA107-1FB2-48FE-B2AB-D878EE1C608EQ30032301-799F4091-C6EA-432A-9490-43CCADDD3086Q30431810-BF68AED8-72D0-47C1-AE7A-7CDA473C0023Q30497845-73CEBE9C-D816-45CA-8163-F98D8BA1434DQ30539979-EEFCE8EB-F1DD-44B2-8117-ABF85E114E84Q33726831-285E2AAF-BF07-4D9E-B06B-27BB767ACB97Q33786537-90599B2C-EBC1-4A53-AEF2-F61A69462145Q33804587-916191C3-A06F-4588-B207-9E0B4FEB4493Q33836224-E0458058-74D2-4A3F-8BFC-178C248CF03AQ33839157-307EC199-78CA-4259-BE63-551DC0492941Q33963659-47A205AF-860C-4BAA-96E6-A74BB6CC0892Q34006701-1657466F-7C80-486A-9A72-947CD7EB7B19Q34020532-BA67CE8B-89F9-449E-84C1-2D5C354AA02AQ34283149-F888FAB7-55CD-4765-ACDD-9F533F06E0ABQ34374743-171D8D83-5083-4C4F-A131-AC2B069B5E99Q34380479-1A02C85E-31DA-436F-A33A-B7AE8C422C56Q34504659-15A11566-5B86-4EBA-AEF1-B42689730A56Q34555967-149A3F7E-8C4A-46EB-B678-24F583316064Q34590202-32B4C17F-6D19-4B8D-85D0-2F7EF9B8180DQ34609073-B6766074-3765-4D95-A417-C8307D638C21Q34748678-95F2DCBD-E925-4865-8B31-670A2A5952F9Q34868333-BF8DA9A7-418E-412E-B86F-364EF97EE866Q34976296-071FEABB-A2B1-42AC-B8DD-095C23C98BD3Q35027999-6DD0A007-8C47-4556-9593-A739225C60A5Q35053727-F06DADCA-F6B2-4785-872D-551DFE32217CQ35573431-1C03F2B1-8D19-4797-9A95-834082969633
P2860
Quantitative assessment of cortical synaptic density in Alzheimer's disease.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Quantitative assessment of cortical synaptic density in Alzheimer's disease.
@en
Quantitative assessment of cortical synaptic density in Alzheimer's disease.
@nl
type
label
Quantitative assessment of cortical synaptic density in Alzheimer's disease.
@en
Quantitative assessment of cortical synaptic density in Alzheimer's disease.
@nl
prefLabel
Quantitative assessment of cortical synaptic density in Alzheimer's disease.
@en
Quantitative assessment of cortical synaptic density in Alzheimer's disease.
@nl
P1476
Quantitative assessment of cortical synaptic density in Alzheimer's disease
@en
P2093
P356
10.1016/0197-4580(90)90059-9
P577
1990-01-01T00:00:00Z